Niho S - Search Results

1

Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specified.

Ota T, Kirita K, Matsuzawa R, Udagawa H, Matsumoto S, Yoh K, Niho S, Ishii G, Goto K. Ota T, et al. Among authors: niho s. J Cancer Res Clin Oncol. 2019 Oct;145(10):2495-2506. doi: 10.1007/s00432-019-03012-z. Epub 2019 Sep 7. J Cancer Res Clin Oncol. 2019. PMID: 31494736

2

A case of synchronous double primary lung cancer with neuroendocrine features.

Niho S, Yokose T, Nagai K, Nishiwaki Y, Kodama T, Mukai K. Niho S, et al. Jpn J Clin Oncol. 1999 Apr;29(4):219-25. doi: 10.1093/jjco/29.4.219. Jpn J Clin Oncol. 1999. PMID: 10340047

3

Clonal analysis of adenosquamous carcinoma of the lung.

Niho S, Yokose T, Kodama T, Nishiwaki Y, Mukai K. Niho S, et al. Jpn J Cancer Res. 1999 Nov;90(11):1244-7. doi: 10.1111/j.1349-7006.1999.tb00703.x. Jpn J Cancer Res. 1999. PMID: 10622536 Free PMC article.

4

Phase I study of cisplatin and docetaxel plus mitomycin C in patients with metastatic non-small cell lung cancer.

Hosomi Y, Ohe Y, Mito K, Uramoto H, Moriyama E, Tanaka K, Kodama K, Niho S, Goto K, Ohmatsu H, Matsumoto T, Hojo F, Kakinuma R, Nishiwaki Y. Hosomi Y, et al. Among authors: niho s. Jpn J Clin Oncol. 1999 Nov;29(11):546-9. doi: 10.1093/jjco/29.11.546. Jpn J Clin Oncol. 1999. PMID: 10678557 Clinical Trial.

5

Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen.

Niho S, Nishiwaki Y, Goto K, Ohmatsu H, Matsumoto T, Hojo F, Ohe Y, Kakinuma R, Kodama T. Niho S, et al. Lung Cancer. 2000 Mar;27(3):159-67. doi: 10.1016/s0169-5002(99)00100-2. Lung Cancer. 2000. PMID: 10699689

6

Phase I studies of cisplatin and docetaxel administered by three consecutive weekly infusions for advanced non-small cell lung cancer in elderly and non-elderly patients.

Ohe Y, Niho S, Kakinuma R, Kubota K, Matsumoto T, Ohmatsu H, Goto K, Kunitoh H, Saijo N, Nishiwaki Y. Ohe Y, et al. Among authors: niho s. Jpn J Clin Oncol. 2001 Mar;31(3):100-6. doi: 10.1093/jjco/hye019. Jpn J Clin Oncol. 2001. PMID: 11336320 Clinical Trial.

7

A phase I/II trial of cisplatin, docetaxel and ifosfamide in advanced or recurrent non-small cell lung cancer.

Kunitoh H, Akiyama Y, Kusaba H, Yamamoto N, Sekine I, Ohe Y, Kubota K, Tamura T, Shinkai T, Kodama T, Goto K, Niho S, Nishiwaki Y, Saijo N. Kunitoh H, et al. Among authors: niho s. Lung Cancer. 2001 Aug-Sep;33(2-3):259-65. doi: 10.1016/s0169-5002(01)00189-1. Lung Cancer. 2001. PMID: 11551421 Clinical Trial.

8

[Tumor markers in lung cancer].

Niho S, Shinkai T. Niho S, et al. Gan To Kagaku Ryoho. 2001 Dec;28(13):2089-93. Gan To Kagaku Ryoho. 2001. PMID: 11791391 Review. Japanese.

9

Phase II study of docetaxel and cisplatin administered as three consecutive weekly infusions for advanced non-small cell lung cancer.

Niho S, Ohe Y, Kakinuma R, Kubota K, Matsumoto T, Ohmatsu H, Goto K, Nishiwaki Y. Niho S, et al. Lung Cancer. 2002 Feb;35(2):209-14. doi: 10.1016/s0169-5002(01)00328-2. Lung Cancer. 2002. PMID: 11804695 Clinical Trial.

10

Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study.

Niho S, Kubota K, Goto K, Ohmatsu H, Matsumoto T, Kakinuma R, Nishiwaki Y. Niho S, et al. Br J Cancer. 2002 Dec 2;87(12):1360-4. doi: 10.1038/sj.bjc.6600658. Br J Cancer. 2002. PMID: 12454762 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters